CoChat
Sign Up
Cited by 219Atrial Fibrillation Management and OutcomesHeart Failure Treatment and ManagementCardiovascular Disease and Adiposity

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

Influence of Obesity on Outcomes in Atrial Fibrillation: Yet Another Obesity Paradox

Badheka, Apurva O., Rathod, Ankit, Kizilbash, Mohammad A., Garg, Neha, Mohamad, Tamam, Afonso, Luis, Jacob, Sony·2010·The American Journal of Medicine
DOI 10.1016/j.amjmed.2009.11.026
Open this paper in CoChat — free account

Abstract

Background Obese patients have favorable outcomes in congestive heart failure, hypertension, peripheral vascular disease, and coronary artery disease. Obesity also has been linked with increased incidence of atrial fibrillation, but its influence on outcomes in atrial fibrillation patients has not been investigated. The objective of this research is to investigate the effect of obesity on outcomes in atrial fibrillation.Methods The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study was one of the largest multicenter trials of atrial fibrillation, with 4060 patients. Subjects were randomized to rate versus rhythm-control strategy. We performed a post hoc analysis of the National Heart, Lung and Blood Institute limited access dataset of atrial fibrillation patients who had body mass index (BMI) data available in the AFFIRM study. BMI data were not available on 1542 patients. Patients with BMI >or=18.5 were split into normal (18.5-25), overweight (25-30), and obese (>30) categories as per BMI (kg/m(2)). Multivariate Cox proportional hazards regression was used on the eligible 2492 patients. End points were all-cause mortality and cardiovascular mortality.Results Over three fourths of all patients in our cohort were overweight or obese. There were 304 deaths (103 among normal weight, 108 among overweight, and 93 among obese) and 148 cardiovascular deaths (54 among normal weight, 41 among overweight, and 53 among obese) over a mean period of 3 years of patient follow-up. On multivariate analysis, overweight (hazard ratio [HR] 0.64; 95% confidence interval [CI], 0.48-0.84; P=.001) and obese (HR 0.80; 95% CI, 0.68-0.93; P=.005) categories were associated with lower all-cause mortality as compared with normal weight. Overweight (HR 0.40; 95% CI, 0.26-0.60; P <.001) and obese patients (HR 0.77; 95% CI, 0.62-0.95; P=.01) also had lower cardiovascular mortality as compared with the normal weight patients.Conclusions Although in prior studies, obesity has been associated with increased risk of atrial fibrillation, an obesity paradox exists for outcomes in atrial fibrillation. Obese patients with atrial fibrillation appear to have better long-term outcomes than nonobese patients.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.amjmed.2009.11.026

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Badheka, A. O., Rathod, A., Kizilbash, M. A., Garg, N., Mohamad, T., Afonso, L., & Jacob, S.
Affiliations
Wayne State University (US)
Corresponding author
Jacob, Sony
ORCID
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
2010-07
Volume
123
Issue
7
Pages
646-651
ISSN
0002-9343 (ISSN-L)
DOI
10.1016/j.amjmed.2009.11.026
OpenAlex
W2071664844
Cited by
219
References
55
Citations by year
2026: 6 · 2025: 11 · 2024: 13 · 2023: 11 · 2022: 11 · 2021: 15 · 2020: 18 · 2019: 12 · 2018: 10 · 2017: 14 · 2016: 20 · 2015: 14 · 2014: 17 · 2013: 15 · 2012: 15
FWCI
10.32
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • The American Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung and Blood Institute
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
obesity, atrial fibrillation, obesity paradox, body mass index, all-cause mortality, cardiovascular mortality, rate control, rhythm control, AFFIRM trial, overweight, mortality risk stratification, atrial fibrillation risk factors, atrial fibrillation prognosis, atrial fibrillation prevention
MeSH terms
Aged, Anti-Arrhythmia Agents, Atrial Fibrillation, Female, Humans, Male, Middle Aged, Obesity, Risk Factors, Cohort Studies, Comorbidity, Proportional Hazards Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review